Stomach cancer, or gastric cancer, is a malignant tumor in the stomach lining1. Early detection of stomach cancer is crucial for improving survival rates and treatment outcomes, with a significant increase in the 5-year survival rate when diagnosed early2. Imaging technology, particularly computed tomography (CT) scans, plays an important role in identifying stomach abnormalities. CT scans provide detailed cross-sectional images, helping to detect suspicious areas, confirm cancer locations, guide biopsies, and determine treatment options3. They are highly effective for advanced gastric cancer and, with recent advancements, are improving in detecting early-stage cancers as well4.
As mentioned above, stomach cancer is a malignant tumor that develops in the stomach lining. It occurs when cells in any part of the stomach grow and divide abnormally, forming a mass or tumor5. Most stomach cancers begin in the glandular tissue on the stomach’s inner surface, resulting in adenocarcinomas.
Common symptoms of stomach cancer include6:
Difficulty swallowing (dysphagia).
Unexplained weight loss.
Abdominal pain.
Persistent indigestion (dyspepsia).
Feeling full after eating small amounts.
Loss of appetite.
Nausea and vomiting.
Dark stools (potentially indicating blood).
Risk factors for stomach cancer include:
Being male (men are twice as likely to develop stomach cancer).
Age over 60.
Infection with Helicobacter pylori bacteria.
A diet high in smoked, pickled, and salted foods.
Smoking tobacco.
Alcohol consumption.
Obesity.
Family history of stomach cancer.
When diagnosed at an early stage, the 5-year survival rate for stomach cancer can be as high as 92.6 percent after endoscopic resection7. In contrast, advanced gastric cancer has a poorer prognosis, with overall 5-year survival rates of around 25 percent in Western countries8.
CT scans are a valuable diagnostic tool in the detection and evaluation of ovarian cancer. They use X-ray technology to create detailed cross-sectional images of the body, providing more information than traditional X-rays9.
CT scans work by rotating an X-ray beam around the patient’s body, taking multiple images from different angles10. For stomach imaging, the patient typically lies on a narrow table that moves through a donut-shaped machine called a gantry. As the X-ray tube and detectors rotate around the patient, they capture data that is then processed by a computer to generate detailed cross-sectional images of the abdominal area, including the stomach11.
The non-invasive nature of CT scans makes them a preferred choice for many diagnostic purposes. Unlike exploratory surgery, CT scans can provide detailed internal images without the need for incisions or insertions into the body12. This imaging technique is painless and typically takes only a few minutes to half an hour, depending on the area being scanned13. For abdominal CT scans, which include imaging of the stomach, the actual scanning time is usually around 10 minutes.
CT scans are particularly valuable for diagnosing various conditions affecting the stomach and other abdominal organs, such as infections, inflammatory diseases, cancers, and injuries11. They can also be used to guide biopsies, plan treatments, and monitor the effectiveness of ongoing therapies.
CT scans play an important role in detecting abnormalities in the stomach that might indicate cancer. The process involves3:
Image acquisition: The patient lies on a table that moves through the CT machine. The machine then captures multiple cross-sectional images of the abdominal area11.
Contrast enhancement: Patients may drink oral contrast or receive intravenous contrast to improve the visibility of the stomach and surrounding structures.
Image reconstruction: A computer processes the data to create detailed 3D images of the stomach and nearby organs.
Image analysis: Radiologists examine the images for specific features that might indicate stomach cancer.
Larger tumors are more easily detected and may indicate a higher risk of malignancy. CT scans can confirm the precise location of the tumor within the stomach14. Tumors may appear as:
Endoluminal: Refers to tumors that grow inward, towards the hollow space inside the stomach. These tumors tend to protrude into the stomach cavity, potentially causing obstruction of affecting the stomach’s normal function14.
Exophytic: The tumor grows outward from the stomach wall. These tumors expand towards the outer surface of the stomach, potentially affecting nearby organs or structures as they grow larger15.
Mixed: This type of tumor exhibits both endoluminal and exophytic growth characteristics. It may grow both inward into the stomach cavity and outward from the stomach wall16.
Further research has identified two main types of growth patterns in early stomach cancer: the superficially spreading (Super) type and the penetrating (Pen) type17,18. The Pen type, particularly a subtype called Pen A, which grows expansively and destroys the muscularis mucosae (a layer of the stomach wall), is associated with a less favorable prognosis due to its higher likelihood of spreading to the liver.
Abnormal thickening of the stomach wall can be observed, especially with uneven or non-uniform uptake of contrast material into the tissue19. Changes in the normal three-layered structure of the gastric wall may also be observed.
Different enhancement patterns can provide radiologists with more information about the tumor. For example, areas with low enhancement uptake can indicate mucin pools (a substance that forms mucus found in certain types of cancer) in some types of gastric cancer.
Stomach cancer can spread locally and to distant parts of the body, a process known as metastasis. CT scans are instrumental in detecting these changes. Lymph node involvement, often seen as enlarged regional lymph nodes (>1 cm in short-axis diameter), can signal the spread of cancer nearby14. Distant metastasis may be identified when the cancer spreads to other organs, such as the liver3. Mesenteric fat infiltration, characterized by indistinct tumor margins and streaky densities in the surrounding fat, can indicate further local invasion of cancer into nearby tissues. These findings help assess the extent of the disease and guide treatment planning.
CT scans can reveal additional features of stomach cancer that provide valuable diagnostic information. These include ulceration, which appears as focal tissue defects on the tumor surface, and calcification, visible at high-enhancement uptake within the mass, both of which can indicate more advanced or aggressive forms of the disease.
CT scans are highly valuable for detecting stomach cancer due to their ability to provide detailed cross-sectional images of the abdomen. These scans offer several advantages, including:
Comprehensive imaging: CT scans can simultaneously visualize the stomach, surrounding organs, and potential metastases, providing a complete picture of the extent of disease20.
High accuracy: For advanced gastric cancer, CT scans can achieve an accuracy of 90-100 percent when using multiplanar reconstruction (MPR) and virtual endoscopy techniques4.
Staging capabilities: CT scans are effective in determining the stage of stomach cancer, including local invasion and distant metastases, which is important for treatment planning21.
Non-invasive procedure: Unlike endoscopy, CT scans are non-invasive and can be performed quickly, making them more comfortable for patients.
Guidance for biopsies: CT scans can guide biopsy procedures, ensuring accurate sampling of suspicious areas.
CT scans are valuable imaging techniques, but how do they stack up compared to others?
While endoscopy provides direct visualization of the stomach lining, CT scans offer a broader view of the entire abdomen and can detect metastases. However, endoscopy remains superior for detecting early-stage cancers and cancer staging. Multidetector computed tomography (MDCT) is used to find both distant metastasis and local tumors22.
For stomach cancer imaging, CT scans are often the first-line choice for overall detection and staging, while MRI is helpful for assessing soft tissue details and tumor characteristics3. Furthermore, MRI scans do not use ionizing radiation, making it a safer option for some patients. MRI is also more sensitive than CT for detecting tumor infiltration and spread23.
While PET scans detect metabolically active tumors, they have lower spatial resolution compared to CT scans. Combined PET/CT scans can offer the benefits of both modalities13.
Proper preparation is essential for a successful CT scan.
If your scan requires it, you may have to fast for four hours before your appointment time24. You can drink clear fluids and take medications as normal. Diabetic patients can have a light snack if necessary but should avoid large meals. If contrast material is needed, you might be asked to drink water or a special liquid contrast.
You will likely be asked to change into a hospital gown for the scan. Remove any metal items, including jewelry, from the area being scanned. Wear comfortable, loose-fitting clothing to your appointment.
If your CT requires contrast, an IV line may be placed in your arm or hand to inject the contrast dye25. You might be given an oral contrast to drink, which helps highlight your digestive tract. Before contrast is administered, you should inform your healthcare provider if you have any allergies, especially to iodine or contrast materials.
You should inform your doctor if you’re pregnant or think you might be. Tell your healthcare provider about any medical conditions, recent illnesses, or medications you’re taking. If you’re taking metformin for diabetes, you may be asked to temporarily stop this medication26.
The scan itself is quick, typically taking only 5-10 minutes, though the entire appointment may last up to 40 minutes. You’ll lie on a table that slides into a doughnut-shaped scanner. For neck scans, your head will be positioned on a special headrest with small pads placed around it27. You’ll be asked to remain still and be given breathing instructions or asked not to swallow during the scan.
While CT scans are invaluable in the detection and management of cancer, they do have some limitations and risks. One of the primary concerns is exposure to ionizing radiation, which can potentially increase the risk of cancer over time by damaging living tissues28. To minimize this risk, low-dose CT (LDCT) protocols have been developed, which significantly reduce radiation exposure while still providing diagnostic-quality images.
The use of contrast agents, though beneficial for image clarity, may pose a risk for patients with allergies or impaired kidney function, prompting the consideration of alternative imaging methods such as MRI or ultrasound29.
CT scans demonstrate high accuracy in detecting stomach cancer, particularly for advanced cases. When using multiplanar reconstruction (MPR) techniques, CT scans can achieve an accuracy of up to 90-100 percent for advanced gastric cancers19. The overall accuracy of CT staging for gastric cancers is around 85 percent.
However, CT scans have limitations, especially for early-stage and smaller tumors. The detection rate for early gastric cancers is significantly lower, at 42 percent, using thin-sliced MPR images. For tumors less than 30 mm in size, the detection sensitivity drops to only 16.8 percent30. Furthermore, CT scans may miss cancers in certain locations, such as the mesentery and peritoneum31.
While CT scans are valuable for detecting stomach cancer, they are often used in conjunction with other diagnostic methods to provide a comprehensive evaluation. These complementary tests include:
If a CT scan detects abnormalities that might indicate stomach cancer, your doctor will initiate several further tests to gather more information. They may recommend additional imaging tests to assess the depth of tumor invasion, provide a detailed view of metastases, and examine tumors in other organs like the liver.
You will likely receive a referral to a gastroenterologist or an oncologist who specializes in gastrointestinal cancers. These specialists will review your CT results and recommend the next steps for your diagnosis and treatment plan.
Often, doctors perform an upper gastrointestinal endoscopy to directly visualize the stomach lining and take tissue samples (biopsies) from any suspicious areas. This procedure is crucial for confirming the presence of cancer cells and determining the specific type of stomach cancer34.
In addition, your healthcare team will usually order further blood tests to check your overall health, assess liver and kidney function, and look for tumor markers such as carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 (CA19-9)35. If the results confirm cancer, they may conduct additional tests to determine the cancer stage, which could include laparoscopy—a minor surgical procedure to examine the outside of the stomach and nearby organs.
While CT scans are valuable diagnostic tools, remember that they cannot definitively diagnose stomach cancer. A final diagnosis always requires a biopsy and a pathological examination of tissue samples. Your healthcare team will guide you through each step of the diagnostic process, explaining the findings and implications of each test.
Early detection significantly improves the prognosis for stomach cancer, with survival rates much higher when diagnosed at an early stage. CT scans play a crucial role in identifying abnormalities, guiding biopsies, and assessing the extent of the disease. While highly effective, they work best alongside other diagnostic tools like endoscopy, MRI, and biopsy for a definitive diagnosis. If a CT scan reveals concerning findings, consulting a healthcare provider will ensure timely evaluation and treatment. Understanding the role of imaging in stomach cancer detection empowers patients to take proactive steps toward early diagnosis and improved outcomes.
CT scans are more effective at detecting advanced stomach cancer, but their accuracy for early-stage tumors is lower. Smaller tumors, especially those under 30 mm, can be difficult to detect.
While the scan itself takes about 5-10 minutes, the full appointment may last up to 40 minutes. Radiologists typically analyze the images within a few days, and results are usually available within a week, depending on the healthcare facility.
Yes, a biopsy is necessary to confirm stomach cancer, as CT scans can indicate abnormalities but cannot definitively diagnose cancer. Doctors often perform an upper gastrointestinal endoscopy with a biopsy to examine tissue samples and determine the presence and type of cancer cells.
1. What Is Stomach Cancer? - NCI. May 31, 2023. Accessed March 13, 2025. https://www.cancer.gov/types/stomach
2. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842-13862. doi:10.3748/wjg.v20.i38.13842
3. Tests for Stomach Cancer | Diagnosis of Stomach Cancer. Accessed March 13, 2025. https://www.cancer.org/cancer/types/stomach-cancer/detection-diagnosis-staging/how-diagnosed.html
4. Nagpal P, Prakash A, Pradhan G, et al. MDCT imaging of the stomach: advances and applications. Br J Radiol. 90(1069):20160412. doi:10.1259/bjr.20160412
5. Stomach cancer | Causes, Symptoms & Treatments. Accessed March 13, 2025. https://www.cancer.org.au/cancer-information/types-of-cancer/stomach-cancer
6. Symptoms of stomach cancer. Accessed March 13, 2025. https://www.cancerresearchuk.org/about-cancer/stomach-cancer/symptoms
7. Waddingham W, Nieuwenburg SAV, Carlson S, et al. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterology. 2021;12(4):322-331. doi:10.1136/flgastro-2018-101089
8. Yada T, Yokoi C, Uemura N. The Current State of Diagnosis and Treatment for Early Gastric Cancer. Diagn Ther Endosc. 2013;2013:241320. doi:10.1155/2013/241320
9. CT scan - Mayo Clinic. Accessed December 9, 2024. https://www.mayoclinic.org/tests-procedures/ct-scan/about/pac-20393675
10. Radiology (ACR) RS of NA (RSNA) and AC of. Body CT. Radiologyinfo.org. Accessed March 13, 2025. https://www.radiologyinfo.org/en/info/bodyct
11. Radiology (ACR) RS of NA (RSNA) and AC of. Computed Tomography (CT) - Abdomen and Pelvis. Radiologyinfo.org. Accessed December 9, 2024. https://www.radiologyinfo.org/en/info/abdominct
12. Health C for D and R. Computed Tomography (CT). FDA. Published online August 15, 2023. Accessed December 9, 2024. https://www.fda.gov/radiation-emitting-products/medical-x-ray-imaging/computed-tomography-ct
13. Computed Tomography (CT) Scans and Cancer Fact Sheet - NCI. January 3, 2024. Accessed July 16, 2024. https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet
14. Kim HC, Lee JM, Kim KW, et al. Gastrointestinal Stromal Tumors of the Stomach: CT Findings and Prediction of Malignancy. American Journal of Roentgenology. 2004;183(4):893-898. doi:10.2214/ajr.183.4.1830893
15. Lee DH, Choi BI, Lee MG, et al. Exophytic adenocarcinoma of the stomach: CT findings. AJR Am J Roentgenol. 1994;163(1):77-80. doi:10.2214/ajr.163.1.8010252
16. Lin YM, Chiu NC, Li AFY, Liu CA, Chou YH, Chiou YY. Unusual gastric tumors and tumor-like lesions: Radiological with pathological correlation and literature review. World J Gastroenterol. 2017;23(14):2493-2504. doi:10.3748/wjg.v23.i14.2493
17. Molinari C, Tedaldi G, Rebuzzi F, et al. Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis. Gastric Cancer. 2021;24(2):392-401. doi:10.1007/s10120-020-01135-8
18. Kitamura K, Yamaguchi T, Okamoto K, Nishida T, Takahashi T. Superficial spreading type of early gastric cancer. Br J Cancer. 1996;74(11):1834-1837.
19. Shimizu K, Ito K, Matsunaga N, Shimizu A, Kawakami Y. Diagnosis of Gastric Cancer with MDCT Using the Water-Filling Method and Multiplanar Reconstruction: CT–Histologic Correlation. American Journal of Roentgenology. 2005;185(5):1152-1158. doi:10.2214/AJR.04.0651
20. Radiology (ACR) RS of NA (RSNA) and AC of. Magnetic Resonance Imaging (MRI) - Abdomen and Pelvis. Radiologyinfo.org. Accessed February 12, 2025. https://www.radiologyinfo.org/en/info/mri-abdomen-pelvis
21. Borggreve AS, Goense L, Brenkman HJF, et al. Imaging strategies in the management of gastric cancer: current role and future potential of MRI. Br J Radiol. 2019;92(1097):20181044. doi:10.1259/bjr.20181044
22. Ungureanu BS, Sacerdotianu VM, Turcu-Stiolica A, Cazacu IM, Saftoiu A. Endoscopic Ultrasound vs. Computed Tomography for Gastric Cancer Staging: A Network Meta-Analysis. Diagnostics (Basel). 2021;11(1):134. doi:10.3390/diagnostics11010134
23. Saiz Martínez R, Dromain C, Vietti Violi N. Imaging of Gastric Carcinomatosis. J Clin Med. 2021;10(22):5294. doi:10.3390/jcm10225294
24. CT scan. nhs.uk. October 18, 2017. Accessed December 9, 2024. https://www.nhs.uk/conditions/ct-scan/
25. Rogers DC, Tadi P. Intravenous Contrast. In: StatPearls. StatPearls Publishing; 2024. Accessed December 9, 2024. http://www.ncbi.nlm.nih.gov/books/NBK557794/
26. Imperial College Healthcare. Having a CT Scan. Having a CT Scan - Information for Patients. 2019. Accessed December 9, 2024. https://www.imperial.nhs.uk/-/media/website/patient-information-leaflets/imaging/having-a-ct-scan.pdf?rev=a4168516b0374dbf9ea6214e676c0d79&sc_lang=en
27. CT scan. Newcastle Hospitals NHS Foundation Trust. March 17, 2022. Accessed February 10, 2025. https://www.newcastle-hospitals.nhs.uk/services/radiology/ct-scans/ct-scan/
28. Health C for D and R. What are the Radiation Risks from CT? FDA. Published online March 11, 2018. Accessed December 9, 2024. https://www.fda.gov/radiation-emitting-products/medical-x-ray-imaging/what-are-radiation-risks-ct
29. British Society of Gastointestinal and Abdominal Radiology (BSGAR). Standards for intravascular contrast agent administration to adult patients, Second edition. Published online 2010. Accessed January 9, 2025. https://www.bsgar.org/media/BFCR(10)4_Stand_contrast(3).pdf
30. Wu CX, Zhu ZH. Diagnosis and evaluation of gastric cancer by positron emission tomography. World J Gastroenterol. 2014;20(16):4574-4585. doi:10.3748/wjg.v20.i16.4574
31. Kliewer MA, Brinkman MR, Hinshaw JL. The Back Alleys and Dark Corners of Abdomen and Pelvis Computed Tomography: The Most Frequent Sites of Missed Findings in the Multiplanar Era. J Clin Imaging Sci. 2020;10. doi:10.25259/JCIS_184_2020
32. cancer CCS/ S canadienne du. Diagnosis of stomach cancer. Canadian Cancer Society. November 2019. Accessed March 14, 2025. https://cancer.ca/en/cancer-information/cancer-types/stomach/diagnosis
33. Upper endoscopy. Accessed March 14, 2025. https://stanfordhealthcare.org/medical-conditions/cancer/stomach-cancer/stomach-cancer-diagnosis/upper-endoscopy.html
34. Stomach Cancer Diagnosis and Tests - NCI. April 11, 2023. Accessed March 14, 2025. https://www.cancer.gov/types/stomach/diagnosis
35. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6(3):142-145. doi:10.1007/s10120-003-0240-9